Ormaplatin
Alternative Names: NSC 363812; Tetraplatin; Tetraplatinum; U 77233Latest Information Update: 10 Jan 2000
At a glance
- Originator Pharmacia Corporation
- Developer Nonindustrial source; Pharmacia Corporation
- Class Cytostatics; Platinum complexes; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer